GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » Net Margin %

Ulisse Biomed SpA (MIL:UBM) Net Margin % : -521.05% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Ulisse Biomed SpA's Net Income for the six months ended in Dec. 2024 was €-2.87 Mil. Ulisse Biomed SpA's Revenue for the six months ended in Dec. 2024 was €0.55 Mil. Therefore, Ulisse Biomed SpA's net margin for the quarter that ended in Dec. 2024 was -521.05%.

The historical rank and industry rank for Ulisse Biomed SpA's Net Margin % or its related term are showing as below:

MIL:UBM' s Net Margin % Range Over the Past 10 Years
Min: -9981.82   Med: -731.07   Max: 41.57
Current: -566.79


MIL:UBM's Net Margin % is ranked worse than
69.05% of 995 companies
in the Biotechnology industry
Industry Median: -119.77 vs MIL:UBM: -566.79

Ulisse Biomed SpA Net Margin % Historical Data

The historical data trend for Ulisse Biomed SpA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA Net Margin % Chart

Ulisse Biomed SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial 41.57 -215.71 -895.89 -2,095.76 -566.25

Ulisse Biomed SpA Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 443.43 -594.83 -195.03 -617.51 -521.05

Competitive Comparison of Ulisse Biomed SpA's Net Margin %

For the Biotechnology subindustry, Ulisse Biomed SpA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ulisse Biomed SpA's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ulisse Biomed SpA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ulisse Biomed SpA's Net Margin % falls into.


;
;

Ulisse Biomed SpA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ulisse Biomed SpA's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-5.94/1.049
=-566.25 %

Ulisse Biomed SpA's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-2.871/0.551
=-521.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ulisse Biomed SpA  (MIL:UBM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Ulisse Biomed SpA Net Margin % Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ulisse Biomed SpA Business Description

Traded in Other Exchanges
N/A
Address
Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149
Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines